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Introduction
The basal ganglia are organized into distinct functional subterritories that receive/emit projections from/to specific cortical regions, forming a number of parallel and integrative cortico-striato-thalamo-cortical loops that provide a mechanism for the selection of an action from competing responses (Alexander et al., 1986; Albin et al., 1989; Mink, 1996) . Broad categories of behaviour are thought to map onto specific functional subdivisions within motor, associative and limbic functional domains (Jahanshahi et al., 2015) . At the neurochemical level, the dopaminergic modulation of glutamatergic cortico-striatal afferents, innervating distinct populations of striatonigral and striatopallidal medium-sized spiny neurons, is essential for the regulation of thalamo-cortical output to maintain the spatial selectivity of contextadapted behaviour (Grace et al., 2007) . Spatially focalized alterations in excitatory, inhibitory and modulatory neurochemical ratios within specific functional subsystems may perturb the typical dopamine D1-and D2-receptor mediated modulation of striatonigral and striatopallidal outputs (Tremblay et al., 2015) . Such perturbations may lead to the expression of diverse motor and non-motor features as exhibited by various psychiatric and movement disorders.
Gilles de la Tourette Syndrome (GTS) presents an example of such a disorder with fundamental alterations in the functional dynamics of cortico-striato-thalamo-cortical circuitry (Felling and Singer, 2011) . In essence, patients with GTS are characterized by the presence of motor and vocal tics, which have been defined as rapid, habitual, burstlike movements or utterances that typically mimic fragments of normal behaviour (Leckman, 2002) . Patients often report unpleasant premonitory urge sensations preceding tics that are relieved by their execution (Kwak et al., 2003) . The large majority of patients with GTS also present with other comorbid conditions that include attention deficit hyperactivity disorder (ADHD), obsessive-compulsive behaviour/disorder (OCB/D), depression and anxiety (Hirschtritt et al., 2015) . In current models of GTS pathophysiology, symptoms are thought to arise as a result of the inappropriate activation of specific clusters of striatal neurons, which lead to a burst-like disinhibition of thalamocortical output (Mink, 2001; Albin and Mink, 2006) . Although the therapeutic spectrum for GTS has recently been expanding, current treatment strategies are often unsatisfactory (Singer, 2010) , thus provoking the need for further elucidation of the underlying pathophysiology.
The bulk of current literature on GTS pathophysiology supports the hypothesis of a dysregulated dopaminergic system. This notion was initially supported by clinical evidence of improvements in tics following the administration of dopamine antagonists, synthesis blockers or depletion drugs and the exacerbation of symptoms following the administration of dopaminergic stimulants (Singer, 2010) . Essentially, the implication is that patients with GTS exhibit a hyper-responsive spike-dependent dopaminergic system (Felling and Singer, 2011) . Methodologically varied work has revealed that patients with GTS exhibit alterations in (i) D2 receptor binding; (ii) dopamine active transporter density/binding; and (iii) phasic dopamine transmission in striatal and cortical regions (for review see Singer, 2013) . In summary, a critical distillation of the literature suggests a dysregulation in the firing patterns of dopaminergic nuclei (Singer, 2013) .
Dopaminergic signalling is functionally compartmentalized into two systems: (i) an asynchronous, extra-synaptic, 'tonic-firing' state driven by an intrinsic pacemaker potential that is gated by inhibitory pallidal -aminobutyric acid (GABA) input; and (ii) a synaptically focused, burst-like, 'phasic-firing' state that is dependent on a glutamatergic excitatory drive via the activation of N-methyl D-aspartate (NMDA) receptors (Grace et al., 2007) . The transient phasic release of dopamine into striatal regions has been shown to be driven by functionally relevant stimuli encoding reward-prediction errors (Schultz et al., 1997) , reinforcement-seeking behaviour (Berridge and Robinson, 1998) and the selection of habitual motor programmes (Jin and Costa, 2010) ; functions that have been implicated in the pathophysiology of GTS Worbe et al., 2011; Delorme et al., 2016) .
The interaction between tonic and phasic dopaminergic signalling is believed to potently modulate cortico-striatal input and response selection in ambiguous situations to most effectively guide behaviour (Grace et al., 2007) . Current models indicate that the regulation of dopaminergic signalling is a dynamic process that is sculpted by a spatio-temporal synergy between (i) local feedback mechanisms that are regulated by the action of tonically-driven, extra-synaptic dopaminergic concentrations on somatodendritic and presynaptic D2 autoreceptors (Rice et al., 2011) ; and (ii) glutamatergic input that is impeded and gated by pallidal GABAergic and mesencephalic cholinergic afferents, respectively (Floresco et al., 2001 (Floresco et al., , 2003 . Thus, the irregular afferent modulation of dopaminergic nuclei would have profound effects on tonic/phasic dopaminergic release in the striatum and the control of subsequent thalamo-cortical output (Grace, 1991 (Grace, , 1993 .
In view of (i) the close synergy exhibited between excitatory, inhibitory and modulatory neurotransmitter systems within the striatum and throughout the brain; and (ii) the interdependent metabolic relationship exhibited between glutamate (Glu), and GABA via the non-neuroactive metabolic intermediate glutamine (Gln) (Waagepetersen et al., 2007) ; one can postulate that if a dopaminergic abnormality were present, other neurotransmitter systems would exhibit perturbations as well . Along this line of reasoning, separate groups have demonstrated that adult patients with GTS exhibit alterations within the GABAergic system in cortical regions using in vivo 1 H magnetic resonance spectroscopy (MRS) (Draper et al., 2014; Tinaz et al., 2014) and subcortical regions using PET (Lerner et al., 2012) . Additionally, previous ex vivo work has also indicated that striatal and pallidal nuclei exhibit alterations in the distribution of fast-spiking GABAergic (Kalanithi et al., 2005) and tonically-active cholinergic interneurons (Kataoka et al., 2010) . These results lend support to the notion of extant irregularities in the modulatory mechanisms governing cortico-striatal input and output selection in GTS.
Given the crucial role of the glutamatergic excitatory drive on the phasic dopaminergic response and the extensive interactions exhibited between the two systems, we postulate that patients with GTS exhibit alterations in glutamatergic signalling . This hypothesis is further supported by: (i) a post-mortem report indicating reductions in Glu concentrations in pallidal and nigral regions in a sample of four patients (Anderson et al., 1992) ; (ii) genomic-based studies indicating linkage to regions overlapping with Glu transporter genes (Barr et al., 1999; TSAICG, 2007; Adamczyk et al., 2011) ; (iii) a gene-set-based analysis implicating astrocyte metabolic coupling mechanisms (de Leeuw et al., 2015) ; (iv) a transcriptome analysis indicating downregulation of glutamatergic synapse genes (Lennington et al., 2016) ; and (v) a study indicating that the disruption of NMDA-dependent dopaminergic burst firing attenuates the acquisition of conditioned behavioural responses and cue-dependent learning (Krabbe et al., 2015) .
As the role of glutamatergic signalling has not been thoroughly investigated in adult patients with GTS in vivo, we aimed at investigating the neurochemical profile of cortical and subcortical cortico-striato-thalamo-cortical regions in a well-characterized group of adult patients via 1 H-MRS for the first time. To this end, we used novel analysis techniques to mitigate the effects of motion artefacts and to obtain absolute concentration estimates for a more reliable evaluation of subtle metabolite changes. We additionally used a longitudinal study design to investigate the influence of treatment on Glu and Gln concentrations in a subset of patients that were treated with the atypical, second-generation antipsychotic aripiprazole.
Materials and methods

Population sampling
The study was approved by the local Ethics Committees. All participants gave written informed consent and received monetary compensation for their participation. Forty-three right-handed adult patients with GTS (seven female; 18-65 years) were recruited from the outpatient psychiatry clinic at Hannover Medical School. Demographic and clinical data of all subjects included in the final analysis are summarized in Table 1 . Patients were deemed ineligible if they exhibited severe tics to the head and face, contraindications to magnetic resonance (MR) examinations, a history of other significant neurological disorders and current abuse of drugs and alcohol. Patients using any psychoactive substances underwent a 4-week washout period before participation. After baseline data acquisition, a subset of patients (n = 17) received treatment with oral aripiprazole, which was administered using a titration procedure commencing at 2.5 mg/day up to maximum daily dosage of 30 mg based on treatment response. All patients were diagnosed based on DSM-5 criteria and underwent a thorough clinical assessment battery. The Yale Global Tic Severity Scale (YGTSS) (Leckman et al., 1989) and the modified Rush Video-based Tic Rating Scale (RVTRS) (Goetz et al., 1999) were used to capture tic severity, while the Premonitory Urge for Tics Scale (PUTS) (Woods et al., 2005) was used to assess premonitory urges. Clinical information was also collected on comorbid features using various scales that include the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) (Goodman et al., 1989) and the Revised ObsessiveCompulsive Inventory (OCI-R) for OCD; the Beck Depression Inventory (BDI-II) (Beck, 1961) for depression; and the Conners' Adult ADHD Rating Scale (CAARS) (Conners et al., 1999) for ADHD. Psychiatric comorbidities were diagnosed as described in the Supplementary material. Forty age-and sex-matched healthy control subjects (eight female, 18-65 years) without a history of neurological, psychiatric and tic disorders were also recruited and assessed in a similar manner as the patients. A subset of the control subjects (n = 23) were invited for a second MR exam for test-retest reliability measurements. All subjects were instructed not to drink coffee or tea, and to abstain from smoking for at least 2 h before the examination. Subjects were also instructed to adhere to a regular sleeping cycle the night before the scan. To minimize the variability that could arise from circadian physiological effects (Soreni et al., 2006) , the time of day of the MR exam was matched between patients and controls, with the majority of acquisitions conducted between 10 am and 4 pm.
Magnetic resonance data acquisition
Magnetic resonance measurements were performed on a 3 T MAGNETOM Verio (Siemens Healthcare) equipped with a 32-channel head coil. The patients were instructed to remain still without actively suppressing their tics and thinking of nothing in particular. Overall, the scanning session lasted $75 min and included the acquisition of self-report data on the degree of tic-urges and tic-suppression (Supplementary material). A landmark-based pre-scan gradient-echo sequence provided by the vendor (Auto-Align Head, AAH) was applied at the beginning of each scan for automatic detection of the crista galli and the tip of the occipital bone within the mid-sagittal plane (Scott, 2006; Dou et al., 2015) . The geometric information was subsequently applied on all imaging protocols and saved for the retest scans. T 1 -weighted images were acquired in the first AAH space using a 3D magnetization-prepared 2 rapid gradient echo (MP2RAGE) sequence (Marques et al., 2010) : repetition time, = 5 s; echo time = 3.93 ms; inversion times = 0.7/2.5 s; sagittal slab orientation; acquisition matrix 256 Â 256 Â 176, and 1 Â 1 Â 1 mm 3 nominal resolution (Streitbü rger et al., 2013) . To minimize errors that arise from bulk head-displacement between the anatomical and spectral acquisitions, single-shot 'dummy' spectra were localized on the MP2RAGE image immediately after acquisition. The (fast) AAH sequence was applied again before each MRS acquisition to co-register the 'dummy' scan geometry to the newly defined space. For the retest scans, the same procedure was used to automatically relocalize the MRS voxel to the same region. Motivated by previous imaging, genetic and post-mortem work (Anderson et al., 1992; Greene et al., 2013; Singer, 2013; Lennington et al., 2016) , 1 H spectra were acquired from three cuboid regions of interest, with Point-RESolved Spectroscopy (PRESS) (Bottomley, 1984) and echo time = 30 ms; repetition time = 3 s; 1024 time-domain data points; 80 (regions of interest 1 and 2; see below) or 128 (region of interest 3) water-suppressed and 16 waterunsuppressed averages. A first 25 Â 16 Â 16 mm 3 voxel was prescribed on the anterior mid-cingulate cortex (aMCC) with the centre on the level of the genu of the corpus callosum and an orientation parallel to the hippocampal axis (Fig. 1A) . A second 28 Â 16 Â 16 mm 3 voxel was centred on the bilateral thalamus while maximizing the amount of grey matter (Fig.  1B) . A third 20 Â 15 Â 20 mm 3 voxel was localized within the left corpus striatum as anterior as possible to include maximal portions of the caudate; as inferior as possible to include the most inferior portion of the putamen; and as medially as possible without including any portions of the lateral ventricles (Fig. 1C) . On average, the voxel contained grey matter portions from the putamen (63.2%), pallidum (22.3%), caudate (12.8%) and nucleus accumbens (1.7%). Regions of interest were shimmed automatically using FASTESTMAP with four to five iterations (Gruetter, 1993; Gruetter and Tká c, 2000) .
Absolute metabolite quantitation
As MRS measurements involve the summation of multiple averages to build the signal-to-noise ratio, subject motion and drifts in the magnetic field during acquisition cause frequency and phase errors (Near et al., 2015) . Such drifts give rise to incoherent signal averaging, line broadening, line shape distortion and reduced signal-to-noise ratio, which may ultimately affect metabolite quantitation and group comparisons. As such, non-averaged time-domain raw data were exported from the scanner and a non-linear least-squares minimization operation was used to fit each signal average, S t ð Þ, (where t is time) to a reference scan, S ref ðtÞ (here taken to be the first average), by the adjustment of the frequency, !, and phase, ', of the signal according to (Near et al., 2015; Simpson et al., 2016) :
To enable fitting of complex data while avoiding non-physical parameter estimates, the vectors SðtÞ and S ref ðtÞ were modified prior to minimization by concatenating their real and imaginary parts into a single real-valued vector. Motion corrupted outlier signals were additionally removed prior to spectral averaging. This was accomplished by calculating the root mean square of the difference spectrum between each individual acquisition and the average and discarding acquisitions deviating by more than 3 standard deviations (SD) from the mean (Simpson et al., 2016) . The performance of the algorithm is demonstrated in Fig. 1 .
The water signal from the non-suppressed spectra was used as a concentration reference. However, spectroscopic voxels in different subjects contain varying proportions of grey matter, white matter and CSF; the grey and white matter compartments have different water concentrations with different T 1 and T 2 relaxation times for water; and negligible signals of most metabolites arise from the CSF compartment. To consider tissue compartmentation, the MRS voxel was first registered to anatomical space by calculating the transformation matrix from the raw file header, and a binary mask representing the voxel limits was then constructed to map the voxel onto the anatomical image (Lee et al., 2013; Edden et al.,
2014
). SPM12 New-Segment (http://www.fil.ion.ucl.ac.uk/ spm) was used to automatically segment the brain into probabilistic grey matter, white matter and CSF maps, which were binned at 0.5 to make the three tissue classes add up to 100%. The grey matter masks were optimized to include subcortical nuclei generated via FSL-FIRST's Bayesian model-based segmentation of subcortical nuclei (Patenaude et al., 2011) . Within-voxel tissue proportions were then calculated based on the optimized tissue segmentation masks. Averaged frequency-and phase-drift-corrected spectra were fit with anterior mid-cingulate cortex (aMCC), (B) bi-lateral thalamus and (C) corpus striatum on MP2RAGE images in single subject. (D) The effect of frequency-and phase-drift (FPD) correction on data acquired from a striatal voxel of a GTS patient (top) is clearly visible in the corrected data (bottom). The performance of the non-linear least-squares minimization operation is illustrated on a single scan (the 25th average) superimposed on the reference signal (inset plots). For the aMCC spectra, which exhibited a high signal-to-noise ratio (SNR), spectral registration was conducted on an approximate range between 1.8-4.2 ppm (red shaded area). For spectra with a lower SNR, the strength of the water signal was used for spectral registration on an approximate range between 4.2-7.5 ppm (green shaded area). (E) The benefit of the correction on the linewidth and SNR is clearly visible on the red coloured spectrum. As some of the spectra exhibited a spurious residual signal in the ppm range between 3.6-4.0 ppm (blue shaded area), possibly due to insufficient spoiling, the LCModel fitting range was adjusted to 0.2-3.67 ppm (orange shaded area).
LCModel (Provencher, 1993) . As some spectra contained artefacts in the frequency range 43.7 ppm, presumably due to insufficient spoiling, spectral fitting was performed in a 0.2-3.67 ppm range. Results for the default 0.2-4.0 ppm range exhibited correspondence and are not presented here. For final inclusion into the statistical models, a step-wise semi-automated quality-control method was used. Detectable metabolites were first identified for each voxel in the control sample if the relative Cramér-Rao lower bounds (CRLBs) of a given metabolite were below 100% in at least 50% of the subjects (Tká c et al., 2009). Cut-off values of absolute CRLBs (CRLB lim , defined as 50% of the mean metabolite concentration in the control sample) were then calculated for each metabolite to threshold cases with excessive fitting errors (Kreis, 2016) . Final inclusion criteria were: (i) correct voxel prescription; (ii) signal-to-noise ratio 4 10 (LCModel output); (iii) fullwidth at half-maximum (FWHM) 5 11 Hz (LCModel output) for good quality spectra; and (iv) absolute CRLB 5 CRLB lim for individual metabolites. All surviving spectra were visually inspected to ensure the quality of included data. Within-voxel compartmentation was considered by applying Equation 2 (Gussew et al., 2012) :
and
where c m is the metabolite concentration in tissue; c 0 w = 55.6 mol/l is concentration of bulk water (Ernst et al., 1993) ; I m and I w are the amplitudes of the metabolite and the water signal, respectively; and N m is the number of protons within the molecule contributing to the metabolite signal. Partial-voluming and the presence of non-water substances are accounted for by the scaling factor , where f and are, respectively, the volume fraction and relative water content of tissue ( = grey matter, white matter, CSF), and R considers water relaxation. 
Statistical analysis
Statistical analysis was performed in the Python programming language (Scipy v.0.15.1 and Statsmodels v.0.6.1) (Oliphant, 2007; Seabold and Perktold, 2010) . All data exhibited a Gaussian distribution as assessed via the KolmogorovSmirnov test. Between-and within-group differences for all metabolites were assessed using two-way independent sample t-tests and paired-sample t-tests, respectively, with a significance level set at P 5 0.05 (uncorrected). A multiple-linear-regression model accounting for age and gender was used to examine the relationship between Gln/Glu concentrations and clinical measures (YGTSS total-tic score, RVTRS, PUTS, Y-BOCS and CAARS). Metabolite test-retest reliability measures
were assessed in the control sample by calculating the coefficient of variation, percentage difference and paired-sample ttests. The reliability of spatial relocalization was assessed using the Sørensen-Dice metric (Dice, 1945; Sørensen, 1948) .
Results
Demographic and clinical characteristics
Complete datasets were acquired from 37 of 43 recruited patients and 36 of 40 recruited controls. MR data were not collected from (i) three patients and three controls due to severe head motion during acquisition; (ii) two patients and one control due to claustrophobia; and (iii) one patient due to previously unreported MR contraindications. Seventeen of 37 patients underwent a 4-week aripiprazole therapy, and complete datasets were collected from 15 patients. Control and patient subjects were comparable in terms of age [t(71) = 0.045, P = 0.96], gender (Fischer's odds ratio 0.80, P = 0.76) and handedness ( 
Test-retest reliability
The Sørensen-Dice metric quantifying the spatial overlap of test-retest localization yielded means and SDs of 0.80 AE 0.10 for the aMCC, 0.83 AE 0.10 for the thalamus, and 0.80 AE 0.09 for the striatum, indicating high repeatability of our localization technique ( Supplementary Fig.  1 ). Assessing the reliability of the spectral measurements (Supplementary Table 3 ), we found no significant differences in (i) spectral quality parameters (full-width at half-maximum, signal-to-noise ratio); and (ii) intra-voxel tissue proportions (white matter, grey matter, CSF). Detectable metabolites (as defined above) included total N-acetylaspartatyl compounds [tNAA; i.e. N-acetylaspartate, NAA, plus N-acetylaspartylglutamate, NAAG], (phospho)creatine (Cre), choline compounds (Cho), Glu, Gln, glutamate plus glutamine (Glx), myo-inositol (m-Ins) and GABA in all voxels, in addition to aspartate (Asp), lactate (Lac) and taurine (Tau) in the aMCC. Concentration estimates were considered unreliable if they exhibited a significant test-retest group difference in the control cohort. Metabolites that failed this criterion included Asp and Lac in the aMCC and m-Ins in the striatum, and were excluded from further analyses. 
Group differences in metabolite concentrations
Correlation of metabolite concentrations with clinical variables
The multiple regression model using age and gender as covariates revealed a significant negative correlation between GTS baseline measurements of striatal Gln concentrations and RVTRS (r = À0.52, P = 0.012) (Fig. 3A) . The analysis also revealed a significant negative correlation between thalamic Glu and PUTS (r = À0.47, P = 0.017) (Fig. 3B ).
Discussion
We hypothesized that glutamatergic signalling is related to pathophysiology of GTS, and aimed at investigating whether patients exhibit alterations in Glu and Gln levels within three cortico-striato-thalamo-cortical regions using 1 H-MRS at 3 T. We report significant reductions in striatal concentrations of Gln, Glx and the Gln:Glu ratio and thalamic concentrations of Glx in patients with GTS when compared to healthy controls. In the subset of patients that underwent a 4-week pharmacotherapy with aripiprazole, we observed significant increases in striatal Glu and Glx concentrations and trends for increases in striatal Gln and thalamic Glx when compared to baseline GTS measurements. ON-treatment patients exhibited no significant differences in detectable metabolites when compared to controls, indicating that the treatment normalized patient metabolite values to control levels. No changes were observed for the aMCC at baseline or after treatment.
Multiple regression analysis revealed a significant negative correlation between left striatal Gln levels and tic severity as measured by RVTRS. Correlation with the YGTSS total tic score was not significant possibly due to the fact that YGTSS assesses tic severity over a period of 7 days, while RVTRS was used to measure actual tics on the day of the scan. Thalamic Glu levels were negatively correlated with premonitory urges as measured by PUTS, suggesting that urges could be viewed as core element of GTS. Although previous work has indicated that the striatal GABA is implicated in GTS pathophysiology (Kalanithi et al., 2005; Kataoka et al., 2010; Lerner et al., 2012) , we did not observe any changes in GABA concentrations. This potentially owes to the fact that our PRESS parameters were optimized for Glu quantitation and the relative difficulty of reliably measuring GABA without using spectral editing techniques ( Supplementary Fig. 5 ) (Mullins et al., 2008 (Mullins et al., , 2014 Hancu, 2009; O'Gorman et al., 2011) .
Altered glutamate-glutamine cycling in GTS
A primary difference between amino acid neurotransmitters (e.g. Glu, GABA) and non-amino acid neurotransmitters (e.g. dopamine) is their relative ubiquity and their participation in numerous biochemical processes. Apart from its role in excitatory neurotransmission, Glu is intimately associated with (i) energy metabolism, serving as a key intermediate linking the metabolism of carbon and nitrogen; and (ii) neurotransmitter synthesis, where it may serve as a precursor for other neurotransmitters (e.g. GABA) (Waagepetersen et al., 2007) . Given that neurons lack the enzymes necessary for anaplerosis, they are incapable of de novo synthesis of Glu or GABA. As such, the astrocytic synthesis of Gln from its precursors glucose or Glu plays an instrumental intermediary role in the replenishment of vesicular concentrations of synaptically released Glu and GABA (Fig. 4) . The homeostatic mechanisms involved in the synthesis, degradation, and trafficking of Glu, GABA and Gln among the different compartments are instrumental in maintaining the metabolic flux of elements in the GABA-Glu-Gln cycle and the subtle balance between excitatory and inhibitory neurotransmission. Current models segregate Glu into two time-limited compartments: (i) a neuronal compartment containing a larger Glu pool (%80%) characterized by a slow turnover rate; and (ii) a glial compartment containing a smaller Glu pool (%20%) (Waagepetersen et al., 2003; Maddock and Buonocore, 2011) . The shuttling of metabolites among the different compartments requires the active transport of metabolites via neuronal and astrocytic transport elements against their concentration gradients.
13
C-labelled glucose MRS studies have shown that changes in the cycle flux rate are closely matched by changes in the rate of astrocytic glycolysis to support energy-dependent uptake (Sibson et al., 1997 (Sibson et al., , 1998 Rothman et al., 2003) . More recent work has provided evidence that local Glu-Gln cycling is necessary to sustain synaptic excitatory transmitter release (Tani et al., 2014) . As the static concentration of Glu measured by MRS reflects the total Glu pool size, which is involved in varied functions (e.g. oxidative metabolism, neurotransmission), caution is often required when attributing changes in Glu or the composite Glx signal to the integrity of glutamatergic neurotransmission (Shen, 2013) . The metabolic cooperation exhibited by the astrocytic-neuronal system to maintain the uptake of Glu for subsequent Gln synthesis, indicates that MRS-visible changes in Gln or the Gln:Glu ratio may represent a more faithful reflection of the GABA-Glu-Gln cycle flux and the integrity of neurotransmission (Hancu and Port, 2011; Best et al., 2013) . As such, the observed decreases in striatal concentrations of Gln, Glx and the Gln:Glu ratio indicate that patients with GTS exhibit a dysfunctional astrocytic-neuronal coupling system, thus suggesting an abnormality in GABA-Glu-Gln cycling, which may perturb the subtle balance between excitatory and inhibitory neurotransmission. Given that the neurotransmitter NAAG also Metabolite concentrations are reported in mmol/l units. aMCC = anterior mid-cingulate; Cho = choline compounds; CI = confidence interval; Cre = (phospoho)creatine; cSTR = corpus striatum; FWHM = full-width at half-maximum (Hz); Glu = glutamate; Gln = glutamine; Glx = glutamate plus glutamine; m-Ins = myo-inositol; THA = thalamus; tNAA = N-acetylaspartate plus NAA-Glu; SNR = signal-to-noise ratio. Values in bold indicate significance: *P 5 0.05.
exhibits close metabolic links to GABA and Glu (Agarwal and Renshaw, 2012) , it is plausible to suggest that it may exhibit alterations in GTS. However, as we were unable to achieve a reliable separation between NAA and NAAG, our analysis had to be limited to the sum of both metabolite, tNAA, which may be insensitive to changes in NAAG (Landim et al., 2016) . Our results are supported by several gene-based studies that have provided evidence for abnormalities in the cellular trafficking machinery of Glu. Genome scans have provided evidence for linkage to 5p13-q11.2, a region that overlaps with the genomic region encoding the glial Glu transporter gene 1 (SLCA13/EAAT1) (Barr et al., 1999; TSAICG, 2007; Singer et al., 2010) . Other genetic functional work has indicated that a missense variant of a highly conserved residue (E219D) in the gene that encodes that main astrocytic Glu transporter (SLC1A3), conveys a significant increase in Glu uptake in a patient with GTS (Adamczyk et al., 2011) . More recent work using a gene-set enrichment analysis centred on functionally compartmentalized genetic clusters (neuronal, astrocyotic, oligodendrocytic and microglial gene sets) has uncovered a significant association within a single gene set representing the astrocyte carbohydrate metabolism pathway within the astrocytic cluster (de Leeuw et al., 2015) . A focused follow-up analysis revealed that association to GTS was the result of an overall, combined effect of a subset of genetic variants encoding elements involved in the metabolism of Gln, GABA, pyruvate, lactate, glycogen and Metabolite concentrations are reported in mmol/l units. aMCC = anterior mid-cingulate; Cho = choline compounds; CI = confidence interval; Cre = (phospoho)creatine; cSTR = corpus striatum; FWHM = full-width at half-maximum (Hz); Glu = glutamate; Gln = glutamine; Glx = glutamate plus glutamine; m-Ins = myo-inositol; THA = thalamus; tNAA = N-acetylaspartate plus NAA-Glu; SNR = signal-to-noise ratio. Values in bold indicate significance: *P 5 0.05.
tri-carboxylic cycle intermediates. Coupled with our results, these data suggest that the genetic alterations in the mechanisms governing glycolytic, glutamatergic, glutaminergic and GABAergic metabolism influence the astrocytic modulation of neuronal function. Ultimately, this may lead to spatially focalized alterations in glutamatergic and GABAergic neurotransmitter ratios in specific striatal subdivisions that would have profound effects on the afferent modulation of dopaminergic discharge and thalamo-cortical output.
The role of functionally selective modulators in the adaptive stabilization of neurotransmitter systems in GTS
As an atypical second-generation antipsychotic, aripiprazole presents an example of a functionally selective drug that exhibits adaptive pharmacological efficacy that is Figure 2 Spectral localization, fitting and statistical analysis. Left: Sagittal, coronal and axial images illustrating the localization of the cingular (aMCC), thalamic (THA) and corpus striatal (STR) regions of interest. The reconstructed masks were generated based on geometric information extracted from the raw file header. Middle: Exemplary spectra illustrating LCModel fits, baselines and residual signals of frequency-and phase-drift-corrected data. The inset images demonstrate the location of voxels with respect to the grey matter, white matter and CSF compartments, which were used to calculate within-voxel tissue proportions for absolute quantitation. A combination of segmentation outputs from SPM12 and FSL-FIRST was used for accurate masking of subcortical nuclei. Right: Plots illustrating the distribution of Gln, Glu and Glx concentrations in controls (green), GTS patients at baseline (red) and GTS patients following treatment with aripiprazole (blue); **P 5 0.05; *denotes a trend for significance (P 5 0.1).
dependent on the local levels of the endogenous ligand: dopamine (De Bartolomeis et al., 2015) . The concept of functional selectivity postulates that a ligand may produce a mix of effects through the activation or inhibition of a limited number of signal transduction pathways as a result of its ability to induce unique G protein-coupled receptor confirmations (Audet et al., 2009; Mailman et al., 2009) . In contrast to other antipsychotics, aripiprazole exhibits submaximal intrinsic activity despite its high occupancy leading to differential actions on D2 receptors, where it may act as (i) an antagonist when dopamine concentrations are high; and (ii) a partial agonist when dopamine concentrations are low (De Bartolomeis et al., 2015) . Owing to its unique pharmacological profile it has been suggested that aripiprazole may act differentially on dopaminergic release, suppressing phasic release relatively more than tonic release (Hamamura and Harada, 2007; Ma et al., 2015) . While the differential modulation of tonic and phasic dopamine release may provide an explanation for aripiprazole's therapeutic effects in neuropsychiatric disorders, studies have indicated that the complex and potent effects of aripiprazole may be a result of the influence it is able to exert on extra-dopaminergic systems. Apart from its influence on the serotonergic system, gene expression studies have indicated that aripiprazole also modulates the glutamatergic and GABAergic neurotransmitter systems (de Bartolomeis et al., 2015) . Specifically, the chronic use of aripiprazole has been demonstrated to (i) induce the mRNA expression of NMDA receptor subunits enhancing glutamatergic neurotransmission in hippocampal and cortical regions (Segnitz et al., 2011) ; (ii) suppress the mRNA expression of glutamatergic astrocytic transporter genes (SLC1A3/EAAT1, SLC1A2/EAAT2) as well as neuronal transporter genes in hippocampal (SLC1A1/EAAT3) and frontal areas (SLC1A6/EAAT4); and (iii) enhance the expression of presynaptic vesicular transporters in the hippocampus (Segnitz et al., 2009) . Given the significant role exhibited by glutamatergic transporter elements in the astrocytic-neuronal coupling system, decreases in the expression of astrocytic-neuronal transporter elements and increases in the expression of vesicular transporter elements indicate an increase in glutamatergic neurotransmission from hippocampal and frontal cortical regions. On the other hand, aripiprazole has also been demonstrated to influence the mRNA expression of GAD 67 , leading to decreased GABA synthesis in the striatum, prefrontal cortex and somatosensory cortex (Peselmann et al., 2013) . Considering (i) the observed decreases of striatal Gln, Glx and the Gln:Glu ratio at baseline; (ii) increases in striatal Glu and Glx during treatment; (iii) previous work implicating alterations in genes encoding glutamatergic transporters and implying increases in Glu uptake (Barr et al., 1999; TSAICG, 2007; Adamczyk et al., 2011) ; (iv) recent data indicating downregulation in genetic modules encoding glutamatergic synaptic elements (Lennington et al., 2016) ; (v) reported decreases of GABA A receptor binding in striatal, pallidal, thalamic and limbic regions (Lerner et al., 2012); and (vi) reported increases of striatal GABA in the supplementary motor area at baseline (Draper et al., 2014) ; it seems plausible to assert that aripiprazole stabilizes the balance between excitatory and inhibitory neurotransmission in GTS, leading to decreases in tonic cortical GABAergic inhibition and increases in excitatory glutamatergic input feeding into the striatum from frontal and hippocampal areas. Along this line of reasoning, it is possible that the recently published data indicating that agents specific to the glutamatergic system (D-serine, riluzole) are not effective in tic suppression (Lemmon et al., 2015) , as they do not exhibit a functionally selective and adaptive pharmacological profile that targets the multiple systems implicated in GTS. The influence of subcortical GABA-Glu-Gln cycling abnormalities on dopaminergic signalling and the phenomenology of tics
In view of the spatio-temporal synergy exhibited by excitatory, inhibitory and modulatory neurotransmitter systems, we consider the effect of the observed neurochemical perturbations on the local circuit model of subcortical connectivity (Fig. 5) . It has been proposed that tics are generated through the repetitive inappropriate activation of specific striatal sub-territories, leading to the burst-like disinhibition of thalamo-cortical output (Mink, 2001; Albin and Mink, 2006) , with topography playing a key role in the manifesting clinical feature (Tremblay et al., 2015) . Previous work has demonstrated that striatal neurons code the serial order of syntactic natural behaviour (Aldridge and Berridge, 1998) , and that the integrity of dopaminergic receptors, transporters and the neurons innervating them are necessary for instinctive sequential stereotypy (Cromwell and Berridge, 1996; Berridge et al., 2005) . While other neurotransmitter systems implicated in GTS (mainly cholinergic, serotonergic, histaminergic) are known to strongly influence dopaminergic signals within the striatum (Carlsson et al., 1999; Singer, 2013) , the excitatory and inhibitory dissociable afferent systems influencing tonic/phasic dopaminergic output towards the striatum hold a key role in coordinating cortico-striatal input and output selection (Grace, 1991 (Grace, , 1993 Grace et al., 2007) .
Typically, the tonically driven, extrasynaptic release of dopamine into the striatum provide potent regulatory signals that influence the synaptically-focused phasic release of dopamine by acting on D2 autoreceptors (Rice et al., 2011) . As such, alterations in the tone of the intrinsic tonic pulse could directly influence the magnitude of the phasic response and subsequent thalamo-cortical output (Grace et al., 2007) . Previous work has indicated that the maintenance of the tonic dopaminergic pulse is also dependent on glutamatergic and GABAergic signals flowing through the hippocampal-ventral tegmental loop (Floresco et al., 2001 (Floresco et al., , 2003 Lisman and Grace, 2005) . In this Figure 4 Astrocytic-neuronal coupling and the homeostasis of glutamatergic and GABAergic neurotransmission. The schematic illustrates key processes involved in the cycling and metabolism of Glu and GABA in neurons and astrocytes. The rapid transamination of the tricarboxylic cycle (TCA) intermediate -ketoglutarate (-KG) predominates the formation of Glu in both neurons and astrocytes. As the unbranched penta-carbon skeleton of Glu only differs from GABA by a single carboxyl group, Glu and GABA exhibit close metabolic links; where GABA is directly synthesized from Glu via glutamate decarboxylase (GAD 65 or GAD 67 ) and is catabolized into Glu via transamination (Waagepetersen et al., 2007) . Given that neurons lack the enzyme pyruvate dehydrogenase, which is needed to link glycolytic metabolism to the TCA cycle, they are unable to replenish their vesicular concentrations of synaptically released Glu. As such, Gln plays an instrumental role in maintaining the homeostasis of Glu and GABA. Once released into the synaptic cleft, Glu is actively shuttled into astrocytes where it is either converted to glutamine via the glial exclusive enzyme glutamine synthetase (GS), or assimilated into the TCA cycle for energy metabolism (A). As a non-toxic and non-neuroactive equivalent, Gln is released by astrocytes where it is taken up by presynaptic neurons to serve as a Glu precursor. On the other hand, the majority of synaptically released GABA is taken up by presynaptic neurons where it is able to re-enter the vesicular pool or enter the TCA cycle via the GABA shunt (B). A fraction of synaptically released GABA is also taken up by astrocytes where it eventually generates Gln following successive steps in the GABA shunt and the TCA cycle (Patel et al., 2005) . Once released by astrocytes, Gln is taken up by presynaptic GABAergic neurons where it is serves as a precursor for GABA via glutamate. As such, the homeostatic mechanisms involved in the synthesis, degradation, and trafficking of Glu and GABA are instrumental in the maintenance of the subtle balance of excitation and inhibition. The observed decreases in striatal concentrations of Gln, Glx and the Gln:Glu ratio are consistent with the assumption that patients with GTS exhibit a dysfunctional astrocytic-neuronal coupling system. Perturbations in the GABA-Glu-Gln cycle flux may ultimately lead to spatially focalized alterations in glutamatergic and GABAergic neurotransmitter ratios in specific striatal and pallidal subdivisions that would have profound effects on the afferent modulation of dopaminergic discharge and thalamo-cortical output.
system, glutamatergic output from the hippocampus (ventral subbiculum) towards striatal GABAergic neurons (nucleus accumbens), causes a decrease of the pallidal inhibition of dopaminergic neurons (ventral tegmental area), thus allowing their transition to a tonically active state (Floresco et al., 2001) . On the other hand, as phasic dopamine signalling is critically dependent on an NMDA-receptor mediated glutamatergic excitatory drive, reductions in excitatory input feeding into dopaminergic nuclei would cause alterations in the phasic response. The significant influence of afferent glutamatergic input innervating dopaminergic nuclei was recently demonstrated by Wang et al. (2011) , who observed habit-learning deficits in mice with dopamine neuron specific NMDA1 receptor deletions. The notion of extant irregularities in the dissociable afferent systems influencing dopamine release in GTS, is further supported by reported (i) ex vivo reductions of Glu concentrations within nigral and pallidal areas (Anderson et al., 1992) ; (ii) ex vivo reductions and alterations in the distribution of striatal and pallidal inhibitory interneurons (Kalanithi et al., 2005; Kataoka et al., 2010) ; and (iii) in vivo increases in the binding capacity of nigral GABA A receptors (Lerner et al., Figure 5 Local circuit model of subcortical connectivity. The schematic illustrates the interaction of major neurotransmitter systems involved the regulation of cortico-striatal input and thalamo-cortical output. In essence, the basal ganglia operate through inhibition, dis-inhibition and facilitation, where the intrinsic quiescence of striatal neurons permits the output nuclei [globus pallidus internal (GPi), substantia nigra pars reticulate (SNr)] to hold the thalamus under GABA-mediated tonic inhibition to prevent inappropriate movements. Select movements are facilitated upon the activation of striatal medium-sized spiny neuron populations that reduce the tonic pallido-thalamic output. Coordinated behaviour is thought to ensue as a result of the integrated output of the D1-(direct-pathway, shaded green) and D2-(indirect-pathway, shaded red) receptor mediated medium-sized spiny neurons, whose outputs arbitrate the selection of the ultimate program (Calabresi et al., 2014; Smith et al., 2014) . Dopamine exerts a powerful influence over output by modulating cortico-striatal afferents innervating medium-sized spiny neurons as well as tonically active cholinergic interneuron (TAN) populations, which provide another level of control of medium-sized spiny neurons via widespread axonal collaterals that regulate the fast-spiking GABAergic interneuron (FSI) populations (Tepper and Bolam, 2004; English et al., 2011; Straub et al., 2014) . Alterations in the dissociable afferent systems influencing tonic/phasic dopamine discharge from the ventral tegmental area (VTA) and substantia nigra pars compacta (SNc) may have an influence on modulation of cortio-striatal input and thalamo-cortical output. Previous work has indicated that the maintenance of the tonic dopaminergic pulse is also dependent on glutamatergic and GABAergic signals flowing through the hippocampal-ventral tegmental loop (not shown) (Floresco et al., 2001 (Floresco et al., , 2003 Lisman and Grace, 2005) . On the other hand, phasic dopamine signalling is critically dependent on an NMDA-receptor mediated glutamatergic excitatory drive emanating from prefrontal, subthalamic and pedunculopontine regions (Floresco et al., 2001; Watabe-Uchida et al., 2012) . Consequently, chronic perturbations in the flux of metabolites in the GABA-Glu-Gln cycle, could lead to focal alterations in excitatory and inhibitory neurotransmitter ratios and subsequent abnormalities in the archetypical dynamics of tonic/ phasic dopamine signalling. This notion is supported by our findings and previous reports indicating reductions and altered distribution of striatal and pallidal FSI and TAN populations. Such perturbations would have a profound influence on the neuro-plastic mechanisms involved in reinforcement learning and habit formation systems that are governed by striatal neurons that code the serial order of syntactic natural behaviour. 2012). As such, chronic perturbations in the subcortical GABA-Glu-Gln cycle flux could lead to spatially focalized alterations in excitatory and inhibitory neurotransmitter ratios and subsequent abnormalities in the archetypical dynamics of tonic/phasic dopamine signalling. Such perturbations would have a profound influence on the neuro-plastic mechanisms involved in reinforcement learning and habit formation systems, which are governed by striatal neurons that code the serial order of syntactic natural behaviour.
Methodological limitations and future directions
Given that patients with GTS are characterized by movement, head displacements during acquisition may have influenced metabolite quantitation. Although we endeavoured to circumvent the potential bias that could be introduced by motion, we cannot completely assert that the motion bias was entirely removed from the data. A more straightforward approach to avoid such bias would be possible with the integration of prospective motion-correction during data acquisition (Keating and Ernst, 2012; Schulz et al., 2012) . Nevertheless, we further investigated the potential influence of within-scan head displacement on spectral measures by performing simulations based on realistic motion parameters and observed no significant effects introduced by motion (Supplementary material). Another potential limitation in our study is that we did not perform multiple comparison corrections, which seems to be a relatively common condition in many hypothesis-driven MRS studies. We believe that our study warrants replication in a larger independent sample focusing on the quantitation of Glu, Gln and GABA. This would particularly benefit from higher magnetic fields (e.g. 7 T) due to improved sensitivity (Tká c et al., 2009) . The assessment of the relationship between spectral measures of Glu, Gln, and GABA in addition to PET measures of dopaminergic signalling, presents a further promising prospect for the elucidation of the nature of GTS pathophysiology.
Conclusion
In this work, we investigated neurochemical profile of a well-characterized sample of adult patients with GTS at baseline and following a 4-week treatment with the antipsychotic aripiprazole using 1 H-MRS at 3 T. To obtain spectra of sufficient precision to identify rather subtle metabolic changes, we applied an automated voxel (re)localization technique, frequency and phase error correction, absolute metabolite quantitation with the consideration of within voxel compartmentation and a careful quality assessment protocol. Our results implicated the flux of metabolites in the GABA-Glu-Gln cycle, thus implying perturbations in subcortical astrocytic-neuronal coupling systems that maintain the subtle balance between excitatory and inhibitory neurotransmission. Such perturbations may ultimately lead to spatially focalized alterations in excitatory, inhibitory and modulatory neurotransmitter ratios in functionally distinct striatal subdivisions, thus leading to the diverse symptomatology associated with GTS.
